Nifedipine increases cholesteryl ester hydrolytic activity in lipid-laden rabbit arterial smooth muscle cells. A possible mechanism for its antiatherogenic effect.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Journal of Clinical Investigation

• Publication date

  1985-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1172/JCI111860PMID 3923040PMCID PMC425495
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Does nifedipine suppress atherogenesis in WHHL rabbits?

  1984cited by this paper
• No Effect of Nifedipine on Atherogenesis in Cholesterol‐Fed Rabbits

  1984cited by this paper
• Metabolic activity of cholesteryl esters in aortic smooth muscle cells is altered by prostaglandins I2 and E2.

  1983cited by this paper
• Verapamil suppresses atherosclerosis in cholesterol-fed rabbits.

  1983cited by this paper
• Calcium antagonists suppress atherogenesis in aorta but not in the intramural coronary arteries of cholesterol-fed rabbits.

  1983cited by this paper
• Arterial neutral cholesteryl esterase. A hormone-sensitive enzyme distinct from lysosomal cholesteryl esterase.

  1983cited by this paper
• Effect of Ca2+ blocking agents on the metabolism of low density lipoproteins in human skin fibroblasts.

  1982cited by this paper
• Prostacyclin modulates cholesteryl ester hydrolytic activity by its effect on cyclic adenosine monophosphate in rabbit aortic smooth muscle cells.

  1982cited by this paper
• Electrophysiologic and hemodynamic effects of slow-channel blocking drugs.

  1982cited by this paper
• Endothelium modifies the altered metabolism of the injured aortic wall.

  1981cited by this paper
• Neutral cholesterol esterase activity in macrophages and its enhancement by cAMP-dependent protein kinase.

  1981cited by this paper
• Phytohemagglutinin stimulation of guanylate cyclase in human lymphocytes.

  1981cited by this paper
• Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine.

  1981cited by this paper
• Lipid accumulation and ultrastructural change within the aortic wall during early spontaneous atherogenesis.

  1980cited by this paper
• Suppression of experimental atherosclerosis by the Ca++-antagonist lanthanum. Possible role of calcium in atherogenesis.

  1980cited by this paper
• Lysosomal acid cholesteryl esterase activity in normal and lipid-laden aortic cells.

  1980cited by this paper
• Phosphorylation of smooth muscle myosin light chain kinase by the catalytic subunit of adenosine 3': 5'-monophosphate-dependent protein kinase.

  1978cited by this paper
• Mechanisms of lipomobilization.

  1978cited by this paper
• Role of cyclic AMP in the actions of luteinizing hormone on steroidogenesis in the corpus luteum.

  1978cited by this paper
• Lipid extraction of tissues with a low-toxicity solvent.

  1978cited by this paper
• Suppression of Calcific Fibrous‐Fatty Plaque Formation in Rabbits by Agents Not Affecting Elevated Serum Cholesterol Levels: The Effect of Thiophene Compounds

  1978cited by this paper
• Experimental aortic lesions of acute serum sickness in rabbits.

  1977cited by this paper
• CHANGES OF CYCLIC‐AMP AND CYCLIC‐AMP PHOSPHODIESTERASE IN THE PROGRESSION AND REGRESSION OF EXPERIMENTAL ATHEROSCLEROSIS

  1976cited by this paper
• The pathogenesis of atherosclerosis (first of two parts).

  1976cited by this paper
• The pathogenesis of atherosclerosis (second of two parts).

  1976cited by this paper
• Activation of adrenal sterol ester hydrolase by dibutyryl cAMP and protein kinase.

  1974cited by this paper
• Separation of six lipid classes on one thin-layer chromatogram.

  1974cited by this paper
• Assay, kinetics, and lysosomal localization of an acid cholesteryl esterase in rabbit aortic smooth muscle cells.

  1974cited by this paper
• LYSOSOMES OF THE ARTERIAL WALL

  1972cited by this paper
• Prevention of vascular lesions by chondroitin sulfate A in the coronary artery and aorta of rats induced by a hypervitaminosis D, cholesterol-containing diet.

  1972cited by this paper
• Simultaneous fluorometric analysis of five lipid classes on thin-layer chromatograms.

  1971cited by this paper
• THE SMOOTH MUSCLE CELL

  1971cited by this paper
• Thromboembolism: A Manifestation of the Response of Blood to Injury

  1970cited by this paper
• Statistical Principles in Experimental Design

  1963cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Transcriptome Analysis of Skeletal Muscle in Pigs with Divergent Residual Feed Intake Phenotypes

  2020cites this paper
• NCEH-1 modulates cholesterol metabolism and protects against &agr;-synuclein toxicity in a C. elegans model of Parkinson’s disease

  2017cites this paper
• Anti-atherosclerotic potential of dihydropyridine calcium channel blockers.

  2012cites this paper
• Interrelationship of Hypertension, Plasma Lipids and Atherosclerosis

  2012cites this paper
• Can the Coronary Atherosclerotic Process Be Influenced by Calcium Antagonists?

  2012cites this paper
• Retardation of development and progression of coronary atherosclerosis: a new indication for calcium antagonists?

  2011cites this paper
• FORMULATION AND EVALUATION OF SUSTAINED RELEASE DOSAGE FORM OF NIFEDIPINE HYDROCHLORIDE USING MULTI-UNIT CHITOSAN TREATED ALGINATE

  2010cites this paper
• Kinetics and mechanisms of cholesterol esterase inhibition by cardiovascular drugs in vitro.

  2006cites this paper
• Dossier: Hypertension and cardiovascular diseases: the rational approach Effects of nifedipine, verapamil and diltiazem on serum biochemical parameters and aortic composition of atherosclerotic chickens

  2005cites this paper
• Evolution of Coronary Atherosclerosis

  2005cites this paper
• Comment Calcium Channel Blockers and Progression of Coronary Artery Disease

  2005cites this paper
• Verapamil and diet halt progression of atherosclerosis in cholesterol fed rabbits

  2005cites this paper
• Antiatherosclerotic effects of calcium channel blockers.

  2002cites this paper
• Lipophilic calcium antagonists in antiatherosclerotic therapy

  2000cites this paper
• Verapamil reduces intimal hyperplasia in a sheep carotid artery patch graft model.

  2000cites this paper
• Effect of felodipine on the serum lipid profile of patients with hypertension

  2000cites this paper
• Cardiac graft vasculopathy: aetiologic factors and therapeutic approaches.

  1998cites this paper
• Impact of a combination of a calcium antagonist and a beta-blocker on cell- and copper-mediated oxidation of LDL and on the accumulation and efflux of cholesterol in human macrophages and murine J774 cells.

  1997cites this paper
• Augmented Ca2+ influx is involved in the mechanism of enhanced proliferation of cultured vascular smooth muscle cells from spontaneously diabetic Goto-Kakizaki rats.

  1997cites this paper
• Effect of lacidipine on cholesterol esterification: in vivo and in vitro studies

  1997cites this paper
• Accelerated arteriosclerosis after transplantation: the possible role of calcium channel blockers.

  1997cites this paper
• In vitro calcium antagonistic and antioxidant effects of Org 13061 and its enantiomers, new potential antiatherosclerotic compounds

  1997cites this paper
• Cholesterol, calcium and atherosclerosis: is there a role for calcium channel blockers in atheroprotection?

  1997cites this paper
• Pharmacological Control of Phagocyte Function: Inhibition of Cholesterol Accumulation

  1997cites this paper
• ect of lacidipine on cholesterol esteri ® cation : in vivo and in vitro studies

  1997cites this paper
• [Calcium antagonists and development of the atheromatous plaque].

  1997cites this paper
• Calcium antagonists and atherosclerosis. Experimental evidence.

  1997cites this paper
• Glucocorticoids stimulate cholesteryl ester formation in human smooth muscle cells.

  1997cites this paper
• Inhibition of vascular smooth muscle cell proliferation by the calcium antagonist clentiazem: role of protein kinase C.

  1996cites this paper
• Felodipine Inhibits Intimal Lesion Formation in the Hypercholesterolemic Rabbit: Differential Effects on Endothelial and Monocyte Determinants of Atherogenesis

  1996cites this paper
• Cytokine Regulation o Arterial Cholesterol Trafficking

  1996cites this paper
• Review: the effects of antihypertensive agents on serum lipids.

  1996cites this paper
• Effect of verapamil and nifedipine on cholesteryl ester metabolism and low-density lipoprotein oxidation in macrophages.

  1995cites this paper
• Effects of efonidipine hydrochloride on cholesterol esterification mediated by beta-very low density lipoprotein in J774 macrophages.

  1995cites this paper
• The Antiatherosclerotic Effect of Calcium Antagonists

  1995cites this paper
• Effects of HL-004, a novel ACAT inhibitor, on cholesterol accumulation and removal in cultured smooth muscle cells from stroke-prone spontaneously hypertensive rats (SHRSP).

  1995cites this paper
• Pharmacological Control of Calcium and Potassium Homeostasis

  1995influential citation
• Lipophilic Dihydropyridines: New Opportunities for Prevention of Atherosclerosis

  1995cites this paper
• Differential and interactive effects of calcium channel blockers and cholesterol content of the diet on jejunal uptake of lipids in rabbits

  1994cites this paper
• Calcium channel blockers and coronary atherosclerosis: from the rabbit to the real world.

  1994cites this paper
• Effect of isradipine on the formation and regression of fatty streaks in cholesterol fed rabbits.

  1994cites this paper
• [Effect of efonidipine hydrochloride (NZ-105), a new dihydropyridine calcium antagonist, on the experimental atherosclerosis in cholesterol-fed rabbits].

  1994cites this paper
• Calcium Antagonists and Lipid-Lowering Agents in the Protection of the Arterial Wall

  1993cites this paper
• Calcium antagonists and cellular mechanisms of glomerulosclerosis and atherosclerosis.

  1993cites this paper
• SIM 6080, a new calcium antagonist, reduces aortic atherosclerosis in cholesterol-fed rabbits.

  1993cites this paper
• Effects of lacidipine on experimental models of atherosclerosis

  1993cites this paper
• Biochemical Mechanisms Associated with the Lipolytic Effects of Calcium Channel Blockers

  1993cites this paper
• Dihydropyridine Ca2+ channel antagonists inhibit the salvage pathway for DNA synthesis in human vascular smooth muscle cells.

  1993cites this paper
• Calcium antagonists and cellular mechanisms of glomerulosclerosis and atherosclerosis.

  1993cites this paper
• Effects of nicorandil on cell proliferation and cholesteryl ester accumulation in arterial smooth muscle cells in culture

  1993cites this paper
• A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients.

  1993cites this paper
• Calcium Channel Blockers as Agents for the Treatment of Atherosclerosis

  1993cites this paper
• The effect of felodipine on the uptake and degradation of acetylated LDL in mouse peritoneal cells and on the distribution of acetylated LDL in macrophage-rich organs of the rat.

  1993cites this paper
• The effect of nifedipine on lipid and monocyte infiltration of the subendothelial space.

  1993cites this paper
• Dihydropyridine calcium antagonist modulates cholesterol metabolism and eicosanoid biosynthesis in vascular cells

  1992cites this paper
• Pharmacological Approaches to the Regression of Atherosclerotic Lesions of the Carotid or Coronary Arteries

  1992cites this paper
• Aspirin abolishes the decreased low-density lipoprotein (LDL) entry into the rabbit arterial wall induced by the calcium channel blocker isradipine.

  1992cites this paper
• The pathogenesis of atheroma and the rationale for its treatment.

  1992cites this paper
• WHICH CALCIUM CHANNEL BLOCKER FOR ISCHAEMIC HEART DISEASE?

  1992cites this paper
• Concept of an antiatherosclerotic efficacy of calcium entry blockers

  1992cites this paper
• Effect of Cilostazol, a Cyclic AMP Phosphodiesterase Inhibitor, on the Proliferation of Rat Aortic Smooth Muscle Cells in Culture

  1992cites this paper
• Kalziumantagonisten und Arteriosklerose - Tierexperimentelle Befunde

  1991cites this paper
• [Drug therapy prevention of coronary sclerosis].

  1991cites this paper
• Atherosclerosis: inhibition of regression as therapeutic possibilities.

  1991cites this paper
• Calcium Antagonists for the Treatment of Atherosclerosis

  1991cites this paper
• Atherosclerosis: cellular aspects and potential interventions.

  1991cites this paper
• Antiatherogenic Properties of Calcium Antagonists

  1991cites this paper
• Effect of nisoldipine on atherosclerosis in the cholesterol fed rabbit: endothelium dependent relaxation and aortic cholesterol content.

  1991cites this paper
• Isradipine, a Calcium‐Entry Blocker, Decreases Vascular [*-I]Low‐Density Lipoprotein Entry in Hypercholesterolemic Rabbits

  1991cites this paper
• Nifedipine: A Pleiotropic Vascular Drug

  1991cites this paper
• Calcium influx modulates DNA synthesis and proliferation in A7r5 vascular smooth muscle cells.

  1991cites this paper
• A nifedipine-sensitive smooth muscle cell population is present in the atherosclerotic rabbit aorta.

  1991cites this paper
• Atherosklerose und Ca++-Kanalblocker

  1991cites this paper
• The Influence of Nifedipine on the Progression of Coronary Artery Disease in Man: The INTACT Study

  1991cites this paper
• Calcium Antagonists and Cholesteryl Ester Metabolism in Macrophages

  1991cites this paper
• Effect of nifedipine on renal microvascular cholesterol accumulation and prostacyclin biosynthesis in cholesterol-fed rabbits.

  1991cites this paper
• [Can drugs, especially calcium antagonists, bring about regression of atherosclerosis, especially coronary sclerosis?].

  1991cites this paper
• Cellular processes in atherogenesis: potential targets of Ca2+ channel blockers.

  1991cites this paper
• Cholesterol enrichment increases basal and agonist-stimulated calcium influx in rat vascular smooth muscle cells.

  1991cites this paper
• Potential Biochemical Mechanisms of the Antiatherogenic Properties of Calcium Antagonists

  1991cites this paper
• [Modification of coronary arteriosclerosis in man by calcium antagonists?].

  1991cites this paper
• Isradipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease.

  1990cites this paper
• Antiatherogenic effects of calcium-channel blockers: Possible mechanisms of action

  1990cites this paper
• Calcium channel blockers and progression of coronary artery disease.

  1990cites this paper
• [The effect of Ca++ antagonists on cellular lipid metabolism].

  1990cites this paper
• Calcium antagonists as anti-atherosclerotic agents.

  1990cites this paper
• Calcium Antagonists: Pharmacologic Agents in Search of New Clinical Indications

  1990cites this paper
• Calcium channel blockers enhance cholesteryl ester hydrolysis and decrease total cholesterol accumulation in human aortic tissue.

  1990cites this paper
• A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis.

  1990cites this paper
• Retardation of coronary artery disease in humans by the calcium-channel blocker nifedipine: Results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy)

  1990cites this paper
• Retardation of development and progression of coronary atherosclerosis: A new indication for calcium antagonists?

  1990cites this paper
• Reduction of Intimal Hyperplasia and Enhanced Reactivity of Experimental Vein Bypass Grafts with Verapamil Treatment

  1990cites this paper
• Influence of nifedipine on experimental arteriosclerosis

  1990cites this paper
• Atherogenesis, calcium and calcium antagonists.

  1990cites this paper
• A new perspective on the antiatherosclerotic activity of Ca2+‐channel blockers

  1990cites this paper
• Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). INTACT Group Investigators.

  1990cites this paper
• Hyperlipidaemia and hypertension.

  1990cites this paper
• Calcium Channel Blockers and Atherosclerosis

  1990cites this paper
• Atherogenesis and the coronary arteries of childhood.

  1990cites this paper
• Calcium channel blockers and atherosclerosis.

  1990cites this paper